• Sulfamethoxazole-trimethoprim, an antimicrobial agent, was used to treat three cases of cytotoxic agent-resistant Wegener's granulomatosis; one case was refractory to a regimen consisting of azathioprine and prednisolone, and in another two cases the therapy was insufficient to control the disease. By the introduction of sulfamethoxazole-trimethoprim, which has an advantage of fewer side effects compared with the conventional agents, into the regimen, the disease condition was markedly improved in all cases within four months. Sulfamethoxazole-trimethoprim is thus considered as one of the most promising drugs to treat, especially, cytotoxic agent-resistant Wegener's granulomatosis. The possible underlying mechanism of the effect of sulfamethoxazole-trimethoprim is also described.
(Arch Otolaryngol Head Neck Surg 1989;115:515-518)
Fukuda K, Yuasa K, Uchizono A, Matsuyama H, Shimada K, Ohyama M. Three Cases of Wegener's Granulomatosis Treated With an Antimicrobial Agent. Arch Otolaryngol Head Neck Surg. 1989;115(4):515–518. doi:10.1001/archotol.1989.01860280113028
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: